This enzyme is involved in the first step of branched chain amino acid (BCAA) catabolism [185] and it has been discovered that BCAT-1 levels are usually high in PD-susceptible regions of the healthy human brain, and that its expression is lower in the substantia nigra of sporadic parkinsonian patients [186]. Here, BCAT1 is linked to Parkinson disease.